Brooke Kern
Psychiatric/Mental Health · Apple Valley, MNNPI 1033576046
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Vanda Pharmaceuticals Inc. at 57.8% of the total. 2025 is the largest year on record at $278, 7.5 times the $37 reported in 2023.
Across 26 payments — averaging $13.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vanda Pharmaceuticals Inc.$200
- Acadia Pharmaceuticals Inc$33
- Supernus Pharmaceuticals, Inc.$32
- Corium, LLC$23
- Lundbeck LLC$17
- Takeda Pharmaceuticals U.S.A., Inc.$15
- plus $28 from 2 others
What the payments were for
- Food & beverage$31491%
- Education$329%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 18 | $200 |
| Acadia Pharmaceuticals Inc | 1 | $33 |
| Supernus Pharmaceuticals, Inc. | 1 | $32 |
| Corium, LLC | 2 | $23 |
| Lundbeck LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| AbbVie | 1 | $13 |
How this compares
$347 in reported general payments places this provider in the 85th percentile of 407 psychiatric/mental health providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylphenidate ErMethylphenidate Hcl | 15 | $1,269 |
| Aripiprazole | 16 | $428 |
| Trazodone Hcl | 17 | $420 |
| Escitalopram Oxalate | 14 | $354 |
| Bupropion XlBupropion Hcl | 11 | $352 |
| Lamotrigine | 13 | $318 |
| Mirtazapine | 15 | $305 |
| Buspirone Hcl | 18 | $221 |
| Sertraline Hcl | 15 | $198 |
| Fluoxetine Hcl | 15 | $163 |
| Zolpidem Tartrate | 14 | $82 |
| Diazepam | 13 | $54 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Apple Valley
- Jacqualine GervaisMoorhead$29K
- Naomi KoenigSandstone$8K
- Dana BageonWayzata$7K
- Jill ScottAnoka$5K
- Holly WillisMinneapolis$5K
- Gerard BalanMinneapolis$5K
- Hilary BreedonShakopee$3K
- Tina AlexanderEdina$3K
- Twilla OskeyBaxter$3K
- Sara OckerCambridge$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.